Jefferies Financial Group Inc.
Position in COLL — Collegium Pharmaceutical, Inc
CIK 96223
NEW YORK, NY
Position in COLL
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$991,880
+$188,279 QoQ
Shares Held
27,400
+12.8% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#107
of 277 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Derivatives in COLL
reported options exposure · as of Dec 31, 2022CallValue
$962,800
CallShares
41,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $24,089,483 across 13 Drug Manufacturers - Specialty & Generic names. COLL ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
370,092 | $9,389,234 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,697 | $3,628,635 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
293,670 | $2,325,866 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
10,630 | $1,791,580 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,304 | $1,534,899 | |
| 6 | ZTS |
Zoetis Inc.
|
18,525 | $1,331,206 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
34,027 | $1,231,777 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
This page
|
27,400 | $991,880 |
All Filings in COLL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $991,880 | 27,400 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $803,601 | 24,300 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,048,312 | 44,240 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,428,509 | 126,565 | Shares | Defined | 2025-11-13 | |
| 2024-09-30 | $1,932,000 | 50,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,334,400 | 352,000 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,580,284 | 40,708 | Shares | Defined | 2024-05-13 | |
| 2022-12-31 | $667,000 | 28,750 | Shares | Defined | 2023-09-21 | |
| 2022-12-31 | $962,800 | 41,500 | Call | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||